Signaling Pathways - Insulin and Insulin-like Receptors - Sphingosine kinases (SphKs) - MSK - Raf
清除全部
- A8716 LY3009120Target: RafSummary: Pan-RAF和RAF二聚体抑制剂
- B3392 GSK269962ATarget: ROCK|RSK|MSKSummary: ROCK抑制剂
- B1298 K145Target: Sphingosine kinases (SphKs)Summary: SphK2抑制剂
- B1174 LGX818中文名: 康奈非尼Target: RafSummary: RAF抑制剂
- B1407 Dabrafenib (GSK2118436)3 Citation中文名: 达拉菲尼Target: RafSummary: BRAF(V600)突变抑制剂
- B2226 SKI IITarget: Sphingosine kinases (SphKs)Summary: 鞘氨醇激酶(SK)抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A8313 RAF265Target: Raf|VEGFRSummary: 多细胞激酶抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂